A meta-analysis of data associating <em>DRD4 </em>gene polymorphisms with schizophrenia

Abstract

To explore the association between DRD4 polymorphisms and schizophrenia risk, a meta-analysis was carried out with 41 case–control articles. Specifically, we included 28 articles (5,735 cases and 5,278 controls) that pertained to the 48 bp variable number tandem repeat (VNTR) polymorphism, nine articles (1,517 cases and 1,746 controls) that corresponded to the 12 bp tandem repeat (TR), six articles (1,912 cases and 1,836 controls) that addressed the 120 bp TR, 10 articles (2,927 cases and 2,938 controls) that entailed the −521 C>T polymorphism, six articles (1,735 cases and 1,724 controls) that pertained to the −616 C>G polymorphism, and four articles (1,191 cases and 1,215 controls) that involved the −376 C>T polymorphism. Pooled analysis, subgroup analysis, and sensitivity analysis were performed, and the data were visualized by means of forest and funnel plots. Results of pooled analysis indicated that the −521 CC variant (Pz=0.009, odds ratio [OR] =1.218, 95% confidence interval [CI] =1.050–1.413) and genotype L/L (ie, long allele) of the 120 bp TR were risk factors of schizophrenia (Pz=0.004, OR =1.275, 95% CI =1.081–1.504). The 48 bp VNTR, the 12 bp TR, the −616 C>G polymorphism, and the −376 C>T polymorphism were not associated with schizophrenia. Additional research is warranted to explore the association between polymorphisms of DRD4 and schizophrenia risk.

Polymorphism rs1801516 (G > A) in the ATM gene is not associated with overall cancer risk: an updated meta-analysis

“…16 We selected the most appropriate genetic model using a previous study. 21,22 We evaluated the degree of inter-study heterogeneity using a Q statistic, 23,24 where P > 0.05 was defined as an absence of heterogeneity. We performed subgroup analysis for ethnicity (e.g., Caucasian or Asian), source of controls (e.g., hospitalor population-based), and type of cancer (i.e., breast cancer, prostate cancer).…”

A meta-analysis of the association between RGS4 gene polymorphisms and schizophrenia

“…To assess the impact of each study on the pooled results, sensitivity analysis was performed by removing single studies in turn. The power was calculated using the PS program [26]. The threshold for statistical significance was P < 0.05 in all tests.…”

TheXRCC4rs1805377 polymorphism is not associated with the risk of cancer: An updated meta-analysis

“…As described in a previous study, 26 OR1 (AA vs. aa), OR2 (Aa vs. aa), and OR3 (AA vs. Aa) were compared, where A is the risk allele, from which the most appropriate genetic model was selected. 27,28 A Q statistic was used to evaluate the degree of inter-study heterogeneity, with the absence of heterogeneity being defined as P > 0.05. 29,30 The I 2 is the proportion of observed variance in effect size attributable to the true differences among studies.…”